Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-30

Clinical Trial Update: Saxagliptin and Cardiac Structure and Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating saxagliptin effects on cardiac structure and function in patients with non-insulin-dependent diabetes mellitus and hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saxagliptin (saxagliptin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetes Mellitus, Non-Insulin-Dependent, Heart Failure | Phase 4 | Status: COMPLETED